Bill Text: TX HB2576 | 2019-2020 | 86th Legislature | Engrossed
Bill Title: Relating to prescribing and dispensing certain controlled substances to patients diagnosed with sickle cell disease.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Engrossed - Dead) 2019-05-10 - Referred to Health & Human Services [HB2576 Detail]
Download: Texas-2019-HB2576-Engrossed.html
86R23773 LHC-D | ||
By: Johnson of Harris, Raymond | H.B. No. 2576 |
|
||
|
||
relating to prescribing and dispensing certain controlled | ||
substances to patients diagnosed with sickle cell disease. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Sections 481.0765(a) and (b), Health and Safety | ||
Code, are amended to read as follows: | ||
(a) A prescriber is not subject to the requirements of | ||
Section 481.0764(a) if: | ||
(1) the patient has been diagnosed with cancer or | ||
sickle cell disease or the patient is receiving hospice care; and | ||
(2) the prescriber clearly notes in the prescription | ||
record that the patient was diagnosed with cancer or sickle cell | ||
disease or is receiving hospice care, as applicable. | ||
(b) A dispenser is not subject to the requirements of | ||
Section 481.0764(a) if it is clearly noted in the prescription | ||
record that the patient has been diagnosed with cancer or sickle | ||
cell disease or is receiving hospice care. | ||
SECTION 2. The change in law made by this Act applies only | ||
to a prescription issued on or after the effective date of this Act. | ||
A prescription issued before the effective date of this Act is | ||
governed by the law in effect on the date the prescription is | ||
issued, and the former law is continued in effect for that purpose. | ||
SECTION 3. This Act takes effect September 1, 2019. |